Xconomy: Bioventus Fleshes Out Bone-Healing Portfolio with BioStructures Deal
Summary
Durham, NC-based Bioventus disclosed no financial terms for the deal, which gives it access to BioStructures’ commercialized bone-healing products, along with technologies still in research and development.Earlier this year, BioStructures received FDA clearance to market Silhouette, a product that incorporates minerals, such as calcium phosphate, into a collagen scaffold meant to help bones heal.Bioventus CEO Tony Bihl said in a prepared statement that the company’s longer-term goal is to develop next-generation bone morphogenetic protein (BMP) technologies.Bihl said that the BioStructures deal builds on the company’s acquisition last year of the OsteoAMP product line from Ladera Ranch, CA-based Advanced Biologics.In 2012, Smith & Nephew spun off the division and formed Bioventus, majority owned by healthcare venture capital firm Essex Woodlands.